• Explore /
  • Poster
  • / REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.

REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.

Abstract Poster

Authors

null

Angelique Vienot

University Hospital of Besançon, Besançon, France

Angelique Vienot , Stefano Kim , Elodie Klajer , Dewi Vernerey , François Ghiringhelli , Christophe Tournigand , Romain Cohen , Stéphanie Husson , Jérôme Desrame , Jean-Baptiste Bachet , Asmahane Benmaziane , Emilie Soularue , Olivier Bouche , Claire Gallois , Eric Assenat , Aurelia Meurisse , Magali Rebucci-Peixoto , Christophe Borg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT05462613

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS3639)

DOI

10.1200/JCO.2024.42.16_suppl.TPS3639

Abstract #

TPS3639

Poster Bd #

297b

Abstract Disclosures

Similar Posters

First Author: Armaan Ahmed

First Author: Margaret Lee

First Author: Hiromichi Maeda

First Author: Meinolf Karthaus